Status:
RECRUITING
Bladder Cancer Screening Trial
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Wilson Charitable Foundation Trust
Pacific Edge Limited
Conditions:
Bladder Cancer
Urothelial Carcinoma
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help asses...
Detailed Description
Bladder cancer is the 4th most common cancer in men and 6th most common cancer overall with over 80,000 new cases in the US per year. The most common causes of bladder cancer are smoking and it is usu...
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 50
- Smoking: ≥15 pack-year smoking history
- Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
Exclusion Criteria:
- Prior history of bladder, kidney, or prostate cancer
- Prior evaluation of micro or gross hematuria within the last 2 years
- Do not provide informed consent
Key Trial Info
Start Date :
May 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05646485
Start Date
May 5 2023
End Date
April 1 2028
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390